← All organizations
Highest phase reached
Phase 4
First clinical trial
Oct 1, 2006Last known activity
May 1, 2022
Timeline
No events for the selected filters.
Drugs by trial phase (5 distinct, 4 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Indications
Recent trials (8)
- NCT05433298Lead sponsorPhase 1/Phase 2May 1, 2022
- NCT05433298Overall official - principal investigatorPhase 1/Phase 2May 1, 2022
- NCT05433298Sponsor investigatorPhase 1/Phase 2May 1, 2022
- NCT04018729CollaboratorPhase 2/Phase 3Aug 5, 2019
- NCT01021878Reponsible party - principal investigatorPhase 4Oct 31, 2009
- NCT01021878Sponsor investigatorPhase 4Oct 31, 2009
- NCT01021878Lead sponsorPhase 4Oct 31, 2009
- NCT02089867Lead sponsorPhase 2/Phase 3Oct 1, 2006
Details
- Last known activity
- May 1, 2022